IKNA: Ikena Oncology, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 71.63
Enterprise Value ($M) 26.44
Book Value ($M) 134.23
Book Value / Share 3.20
Price / Book 0.53
NCAV ($M) 126.78
NCAV / Share 3.03
Price / NCAV 0.57

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -0.28
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 15.32
Current Ratio 15.32

Balance Sheet (mrq) ($M)
Current Assets 141.53
Assets 148.99
Liabilities 14.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
4 days ago 13G Blue Owl Capital Holdings LP 8.48
5 days ago 13G/A Bristol Myers Squibb Co 4.40 0.00
03-11 13G/A Fmr Llc 2.77 -70.96
02-14 13G/A Omega Fund VI, L.P. 4.70 0.00
02-14 13G/A Biotechnology Value Fund L P 9.90 90.53
02-14 13G/A Citadel Advisors Llc 0.40
2023-10-19 13G Gilead Sciences Inc 6.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 10,890 71,849 15.16
2024-11-14 1,560 31,426 4.96
2024-11-13 1,130 11,416 9.90
2024-11-12 2,594 29,554 8.78

(click for more detail)

Similar Companies
HCWB – HCW Biologics Inc. HRMY – Harmony Biosciences Holdings, Inc.
HROW – Harrow, Inc. IMRX – Immuneering Corporation
INAB – IN8bio, Inc.


Financial data and stock pages provided by
Fintel.io